Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: What's on the Horizon for CAR T-Cell Therapies

Article

This OncLive® webinar series will focus on the continued impact of the COVID-19 pandemic on the delivery of cellular therapeutics, particularly chimeric antigen receptor T cells. Join us Tuesday, June 2, 2020 at 8 PM EST.

Date/Time: Tuesday, June 2, 2020 at 8 PM EST

This OncLive® webinar series will focus on the continued impact of the COVID-19 pandemic on the delivery of cellular therapeutics, particularly chimeric antigen receptor (CAR) T cells. We will feature a panel of leading experts to discuss important topics and considerations surrounding CAR T-cell therapies and the patient populations impacted during this time.

Click here to register today!

Course Topics:

  • Highlights from ASCO CAR T-cell abstracts and presentations
  • Updates on CAR T-cell clinical trials
  • New and novel CAR T-cell therapies

Associate Professor Section Chief, Indolent Lymphoma Section Chief, New Drug Development Department Lymphoma/Myeloma UT MD Anderson Cancer Center

Matthew Lunning, DO, Associate Professor, Internal Medicine Medical Director, Lymphoma Research Division of Oncology & Hematology University of Nebraska Medical Center

Ahmed Galal, MD, FRACP, MSc,Professor of Medicine Division of Hematologic Malignancies and Cellular Therapy Duke University School of Medicine

Sponsored By:

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Annaiz Grimm, BS, a research scientist at Seattle Children's Research Institute.
Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine.
Surbhi Sidana, MD, an assistant professor of medicine, bone marrow transplantation, and cellular therapy at Stanford
© 2025 MJH Life Sciences

All rights reserved.